Shengjing Hospital
Shenyang, Liaoning, 110000, China
Location status: Recruiting
Location contact
Anhua Wu, MD
CONTACT
Anhua Wu, MD
PRINCIPAL_INVESTIGATOR
Wen Cheng, MD
PRINCIPAL_INVESTIGATOR
Yu Shi, MD
CONTACT
Yu Shi, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05957679
In spinal cord tumors requiring surgical intervention, the resection difficulty is determined by two significant factors: tumor stiffness and adhesion to surrounding tissue.
The stiffness of the tumor dictates the complexity of removal, while strong adhesion presents additional challenges during the surgical procedure.
This clinical trial aims to assess the clinical utility of magnetic resonance elastography (MRE), in evaluating the stiffness and adhesion of spinal cord tumors and guiding surgical planning to selecting the most appropriate surgical approach for patients with spinal cord tumors.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Shenyang, Liaoning, 110000, China
Location status: Recruiting
Anhua Wu, MD
CONTACT
Anhua Wu, MD
PRINCIPAL_INVESTIGATOR
Wen Cheng, MD
PRINCIPAL_INVESTIGATOR
Yu Shi, MD
CONTACT
Yu Shi, MD
PRINCIPAL_INVESTIGATOR
Spinal cord tumors are a common condition in neurosurgery, including neurofibroma, spinal meningioma, ependymoma, glioma, spinal lipoma, and so on.
Magnetic resonance imaging (MRI) plays a crucial role in the preoperative evaluation and planning of spinal cord tumor surgery. It provides detailed information about the tumor's location, size, and relationship to adjacent structures.
However, routine MRI may not always provide sufficient information about the tumor's stiffness or adhesion, which can impact surgical planning and postoperative outcomes. Magnetic resonance elastography and slip interface imaging can help measure the mechanical properties of tissues, including their stiffness or adhesion.
By combining the above methods, surgeons can identify areas of potential tumor adherence or invasion into surrounding structures, allowing for more precise surgical resection and minimizing the risk of damage to critical neural tissue.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Undergo MRE and routine MRI
Other names: MRE
Undergo grading and recording of tumor stiffness and adhesion during surgery
Time frame: Baseline to 6 weeks
The surgeon will score the tumor stiffness in seven aspects, ranging from 1 to 5 points: Tumor size; Shape of tumor; Tumor texture; Stiffness of the tumor's capsule; Stiffness of the tumor's central region; Primary methods of tumor removal; Features of tumor's capsule.
Time frame: Baseline to 6 weeks
The surgeon will score the tumor's adhesion based on seven aspects, ranging from 1 to 4 points: Stripping instruments; Frequency of use of sharp instruments; Adhesion range; Degree of tumor resection; Cranial nerve anatomy preservation; Brain tissue anatomy preservation; Neurological function (compared with preoperative).
Contact information is provided by the study sponsor or research team.
Wen Cheng, MD
CONTACT
Yu Shi, MD
CONTACT
Shengjing Hospital
Other
Preoperative Evaluation of Tumor Stiffness and Adhesion in Spinal Cord Tumor Using Magnetic Resonance Elastography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00826241
Brain Diseases, Brain Neoplasms
San Francisco, California, United States
View Trial DetailsNCT04743310
Astrocytoma, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT04541082
Anaplastic Astrocytoma, Anaplastic Meningioma
Bethesda, Maryland, United States
View Trial DetailsNCT03434262
Anaplastic Astrocytoma, Anaplastic Ependymoma
Memphis, Tennessee, United States
View Trial Details